CLINICAL_TRIALS
trial_result
· 2013-10-25
Clinical Trial Update: Efficacy and Safety of SP2086 as Monotherapy in Patients With Type 2 Diabetes [Phase 3]
Summary
Phase 3 update on efficacy and safety of SP2086 as monotherapy for Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN